Breaking News

GenScript Adds Circular RNA, Lipid Nanoparticles Formulation

Aims to offer comprehensive range of RNA formats critical, enabling fast delivery of complex design for the R&D of RNA vaccines and therapeutics.

GenScript Biotech Corporation, a provider of life-science research tools and services, expanded its IVT mRNA synthesis portfolio with the addition of customized circular RNA (circRNA) and lipid nanoparticles (LNPs) formulation services. The new contract-manufactured reagent services are available immediately to provide reagents that advance research in fields such as vaccine development, protein replacement therapies, and gene and cell therapy. Circular RNA (circRNA) supports the development ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters